ASTX030 (Azacitidine and Cedazuridine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASTX030 (Azacitidine and Cedazuridine), covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) [Phase 2, Phase 3]